Research update Immunovia: All eyes on securing the launch of PancreaSure
15 maj, 13:35
15 maj, 13:35
Carlsquare Equity Research has updated its view on Immunovia following the publication of the report for the first quarter of 2025.
Read the full update here.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Attachments
Research update Immunovia: All eyes on securing the launch of PancreaSure
15 maj, 13:35
Carlsquare Equity Research has updated its view on Immunovia following the publication of the report for the first quarter of 2025.
Read the full update here.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Attachments
Research update Immunovia: All eyes on securing the launch of PancreaSure
Styrräntan
Aktier
Bostadsmarknaden
Styrräntan
Aktier
Bostadsmarknaden
1 DAG %
Senast
Saab
Igår, 18:57
Frankrike avser köpa Globaleye
Kambi Group
Igår, 18:49
Kambi beslutar om aktieåterköp
OMX Stockholm 30
1 DAG %
Senast
2 458,59